Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond Catalytic Therapy: Copper-Paeonol Nanozymes Disrupt Fascin-Mediated Actin Bundling to Suppress Tumor Growth and Metastasis. | Adv Sci (Weinh) | 2026 | 41405370 | PubTator, text mining | PubMed |
| Selective autophagic degradation of glycolytic activator PFKFB3 contributes to maintaining intestinal epithelial barrier in inflammatory bowel disease. | Int J Mol Med | 2026 | 41384306 | PubTator, text mining | PubMed |
| Xiebai San mediates the NCOA2-ESR1/2 signaling pathway to intervene in interstitial pneumonia. | Phytomedicine | 2026 | 41380416 | PubTator, text mining | PubMed |
| Type II Alveolar Epithelial Cells Promote Sepsis-Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release. | Adv Sci (Weinh) | 2026 | 41178622 | PubTator, text mining | PubMed |
Polyethylene terephthalate microplastics exposure enhances the risk of ulcerative colitis: insights from multiomics integration, machine learning, and molecular docking reveal intestinal toxicity mechanisms. | Int J Surg | 2026 | 40981471 | PubTator, text mining | PubMed |
| Identification of Hypoxia-Related Genes in Human Myocardial Infarction and Cancers. | Cardiology | 2026 | 40795764 | PubTator, text mining | PubMed |
| Investigating the Biomarkers for Alzheimer's Disease: Insights from Microarray Analysis, Mendelian Randomization, and Experimental Validation. | Curr Med Chem | 2026 | 40600553 | PubTator, text mining | PubMed |
| Inhibition of PFKFB3 in Macrophages Has a Dual Effect on Tumor-Regulating Lipid Metabolism. | Int J Mol Sci | 2025 | 41516095 | PubTator, text mining | PubMed |
| Glucose Metabolism and Innate Immune Responses in Influenza Virus Infection: Mechanistic Insights and Clinical Perspectives. | Cells | 2025 | 41511331 | PubTator, text mining | PubMed |
| Investigating the Role of Glycolysis in Xuefu Zhuyu Capsule-Promoted Angiogenesis in Endothelial Cells: A Study Based on Network Pharmacology, Molecular Docking, and In Vitro Validation. | Pharmaceuticals (Basel) | 2025 | 41471391 | PubTator, text mining | PubMed |
| Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosis. | Cell Death Discov | 2025 | 41469416 | PubTator, text mining | PubMed |
| Systematic Exploration of Small-Molecule Binding via a Large Language Model Trained on Textualized Protein-Ligand Interactions. | Molecules | 2025 | 41375113 | PubTator, text mining | PubMed |
| Linking the Warburg effect to endometrial receptivity: metabolic parallels in embryo implantation. | Front Cell Dev Biol | 2025 | 41332984 | PubTator, text mining | PubMed |
| Isoallolithocholic acid ameliorates intestinal inflammation via metabolically reprogrammed macrophages. | Commun Biol | 2025 | 41315591 | PubTator, text mining | PubMed |
| Metabolic enzyme PFKFB3 mediates matrix stiffness-potentiated tumour growth and radiotherapeutic resistance in HCC. | Clin Transl Med | 2025 | 41292194 | PubTator, text mining | PubMed |
| Potential Mechanisms of Lipid-Soluble Vitamins Alleviate Brain Damage in Preterm Infants: Integration of Network Pharmacology and Molecular Docking. | J Cell Biochem | 2025 | 41277467 | PubTator, text mining | PubMed |
| m6A-Dependent Upregulation of PFKFB3 Drives Macrophage-Mediated Inflammation in Necrotizing Enterocolitis. | Antioxid Redox Signal | 2025 | 41239917 | PubTator, text mining | PubMed |
| Panax notoginseng saponin mitigates glycolysis to regulate macrophage polarization and sphingolipid metabolism via hypoxia-inducible factor-1 to alleviate atherosclerosis. | Phytomedicine | 2025 | 41207266 | PubTator, text mining | PubMed |
| PFKFB3 Promotes Myofibroblast Differentiation and Cardiac Fibrosis Through its Intra- and Extra- Cellular Roles. | J Cardiovasc Transl Res | 2025 | 41166052 | PubTator, text mining | PubMed |
| PFKFB3 as a multifaceted driver and therapeutic target in castration-resistant prostate cancer. | Cell Death Dis | 2025 | 41136393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=8